: T2 Biosystems stock falls 16.1% premarket after snapping 3-day winning streak


Shares of micro cap T2 Biosystems Inc.  TTOO, -9.90% plunged 16.1% in premarket trades Thursday. The health diagnostics company’s stock ended Wednesday’s session down 3.8%, snapping a three-day winning streak. The stock fell on trading volume of 335.85 million shares, well above its 65-day average trading volume of 97.38 million shares. T2 has been generating meme-like buzz recently and its stock has risen 468.2% in the last month. The company, which describes itself as a leader in the rapid detection of sepsis-causing pathogens and antibiotic-resistance genes, has a market cap of $197.18 million. T2 shares have fallen 59.9% in 2023, compared with the S&P 500 index’s  SPX, +0.09% gain of 14.7%.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleOutside the Box: Want to run the country? Answer the tough questions about Social Security.
Next articleWhy some economists now foresee an 8% interest rate for 30-year fixed mortgages


Please enter your comment!
Please enter your name here